Abstract:Background: Model for end-stage liver disease (MELD) is an effective predictive marker for renal, hepatic, and cardiac dysfunctions. In this study, we explore the correlation between MELD scores and the outcomes of patients undergoing cardiac valve surgery. Methods: We conducted a retrospective analysis of clinical data from patients who underwent cardiac valve surgery, encompassing procedures on the aortic valve, mitral valve, and tricuspid valve, using the Informative Surgical Patient dataset for Innovative Research Environment (INSPIRE) database, we conducted receiver operating characteristic (ROC) analyses on the study participants and chose MELD as the primary scoring tool for our study due to its optimal area under the curve (AUC), patients were stratified into high (MELD ≥18) and low (MELD <18) groups based on the determined cutoff value. The perioperative clinical data of the two groups were compared. Results: The analysis revealed 751 patients in the low MELD group (75.5%) and 244 patients (24.5%) in the high MELD group. Patients in the high MELD group exhibited a lower body mass index (BMI) compared to those in the low MELD group. In comparison to the low MELD group, the high MELD group exhibited a higher rate of emergency surgery (10.66% vs. 5.99%, P=0.01), along with prolonged anesthesia time, surgery time, and cardiopulmonary bypass (CPB) time. Regarding clinical prognosis, the high MELD group demonstrated a higher 28-day mortality rate (10.66% vs. 0.8%, P<0.001), as also observed in the analysis of three valve subgroups. Additionally, the high MELD group experienced longer hospitalization and intensive care unit (ICU) stay, and a higher proportion of patients requiring mechanical circulatory support, including intra-aortic balloon pump (IABP) assist (14.75% vs. 3.86%, P<0.001), extracorporeal membrane oxygenation (ECMO) assist (7.38% vs. 0.8%, P<0.001), and continuous renal replacement therapy (CRRT) (27.87% vs. 1.46%, P<0.001) post-surgery. The Kaplan-Meier survival curves illustrated a significantly lower mortality rate in the low MELD group compared to the high MELD group, with highly significant statistical differences (P<0.001). Conclusions: The MELD score demonstrates a robust predictive value for clinical outcomes following cardiac valve surgery, underscoring its utility as a viable metric for disease stratification research.

Clinical Study of MELD System Direct Assessment the Degree of Hepatic Fibrosis for LT Patient

A correlation between pretransplantation model for end-stage liver disease score and degree of hepatic fibrosis in explanted livers

Prediction Value of Model for End-Stage Liver Disease Scoring System on Prognosis in the Acute on Chronic Liver Failure Patients with Plasma Exchange Treatment.

A Study on the Relationship Between Ultrasonographic Score and Clinical Score (MELD, CPT) in Cirrhosis.

A clinical study of relationship between noninvasive quantitative ultrasonographic score and clinical score in hepatic fibrosis patients

Evidence-based Incorporation of Key Parameters into MELD Score for Acute-on-chronic Liver Failure

Value of MELD to Assess the Short-term Prognosis of Patients with Chronic Liver Failure

Potential predictive value of MELD score for mortality after liver transplantation

Impact of Pretransplant MELD Score on Posttransplant Outcome in Orthotopic Liver Transplantation for Patients with Acute-on-chronic Hepatitis B Liver Failure.

The Combination of Indocyanine Green Clearance Test and Model for End-Stage Liver Disease Score Predicts Early Graft Outcome after Liver Transplantation

Model for end-stage liver disease score in predicting acute kidney injury and prognosis in patients receiving liver transplantation

Value of ΔMELD in evaluating the prognosis of patients with decompensated cirrhosis

Application of model for end-stage liver disease as disease classification in cardiac valve surgery: a retrospective study based on the INSPIRE database

Application of an end-stage liver disease model in prediction of prognosis in patients with liver cirrhosis

Evaluation on prognosis of survival situation of liver failure patients by using MELD score system

Clinical Value of MELD Score Combined with Serum Preaibumin in Evaluating Liver Function Damage

Fluids Administration and Coagulation Characteristics in Patients with Different Model for End-Stage Liver Disease Scores Undergoing Orthotopic Liver Transplantation

Model for end-stage liver disease-dependent prognostic capacity of platelet-to-lymphocyte ratio following liver transplantation for hepatocellular carcinoma

Therapeutic Evaluation of the Patients with High MELD Scores Undergoing Liver Transplantation for Benign End-Stage Liver Disease

An Evaluation of the Prognosis of Patients with Chronic Severe Hepatitis Using a Model for End-Stage Liver Disease

Model for end-stage liver disease versus the Child-Pugh score in predicting the post-transplant 3-month and 1-year mortality in a cohort of Chinese recipients